Sandoz
Focus: Sandoz is a public global generics and biosimilars company headquartered in Austria, serving immunology, infectious diseases, neurology, cardiovascular, and respiratory markets. As a major player in off-patent pharmaceuticals, the company maintains significant scale but operates in a commoditized, margin-compressed segment.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Sandoz
AI assessmentNot HiringNo open roles listed right now. Follow Sandoz to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
1 in 5yr
SERNIVO
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
LOE Approaching
Represents 24% of company revenue and approaching loss of exclusivity, creating urgent need for pipeline replacement.
Help build intelligence for Sandoz
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.